SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy, commonly progressing from pancreatic intraepithelial neoplasia (PanIN). However, the molecular alterations in PanIN lesions and their contribution to PDAC progression remain poorly defined. Here, using laser capture microdissecti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 13, 2025
|
| In: |
Advanced science
Year: 2025, Jahrgang: 12, Heft: 42, Pages: 1-18 |
| ISSN: | 2198-3844 |
| DOI: | 10.1002/advs.202510071 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/advs.202510071 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202510071 
|
| Verfasserangaben: | Hexing Hang, Mengyu Yu, Linxi Zhu, Neng Tang, Xiao Fu, Zhenghua Cai, Minghao Yan, Yi Chen, Lei Yang, Jianzhuang Wu, Jiatong Tang, Yu Xie, Qi Li, Xu Fu, Liang Mao, Jun Chen, Fanqing Meng, Bo Kong, Xiaodong Han, Chao Yan, Yudong Qiu, and Hao Cheng |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1948551527 | ||
| 003 | DE-627 | ||
| 005 | 20260113104018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260113s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/advs.202510071 |2 doi | |
| 035 | |a (DE-627)1948551527 | ||
| 035 | |a (DE-599)KXP1948551527 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hang, Hexing |e VerfasserIn |0 (DE-588)1386565962 |0 (DE-627)1948551748 |4 aut | |
| 245 | 1 | 0 | |a SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer |c Hexing Hang, Mengyu Yu, Linxi Zhu, Neng Tang, Xiao Fu, Zhenghua Cai, Minghao Yan, Yi Chen, Lei Yang, Jianzhuang Wu, Jiatong Tang, Yu Xie, Qi Li, Xu Fu, Liang Mao, Jun Chen, Fanqing Meng, Bo Kong, Xiaodong Han, Chao Yan, Yudong Qiu, and Hao Cheng |
| 246 | 3 | 3 | |a SPone-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer |
| 264 | 1 | |c November 13, 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Zuerst veröffentlicht: 20. August 2025 | ||
| 500 | |a Gesehen am 13.01.2026 | ||
| 520 | |a Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy, commonly progressing from pancreatic intraepithelial neoplasia (PanIN). However, the molecular alterations in PanIN lesions and their contribution to PDAC progression remain poorly defined. Here, using laser capture microdissection-based proteomics of patient tissues, early metabolic remodeling and upregulation of the transcriptional factor specificity protein 1 (SP1) in PanIN lesions are identified, which persisted into the PDAC stage. That SP1 overexpression promoted PDAC proliferation is demonstrated in patient-derived organoid xenograft models (PDOXs), while deletion of Sp1 inhibited tumorigenesis and progression in a transgenic mouse model of PDAC (KrasLSL-G12D/+; Trp53LSL-R172H/+; Sp1LOXP/LOXP; Pdx1-Cre). ChIP-seq and isotope tracing revealed that SP1 enhances aerobic glycolysis by transcriptionally activating 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB4), a key regulator of glycolysis. Combination therapy targeting SP1 and PFKFB4 demonstrated significant efficacy in PDAC models in vivo. The findings suggest that SP1 is a critical regulator of PDAC initiation and progression through its control of metabolic remodeling. Targeting SP1 and PFKFB4 represents a promising therapeutic strategy for PDAC treatment. | ||
| 650 | 4 | |a metabolic remodeling | |
| 650 | 4 | |a pancreatic cancer | |
| 650 | 4 | |a PanIN | |
| 650 | 4 | |a PDAC | |
| 650 | 4 | |a SP1 | |
| 700 | 1 | |a Yu, Mengyu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhu, Linxi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tang, Neng |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fu, Xiao |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cai, Zhenghua |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yan, Minghao |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Yi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yang, Lei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wu, Jianzhuang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tang, Jiatong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xie, Yu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Li, Qi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fu, Xu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mao, Liang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Jun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Meng, Fanqing |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kong, Bo |d 1981- |e VerfasserIn |0 (DE-588)1015235425 |0 (DE-627)668733195 |0 (DE-576)350346887 |4 aut | |
| 700 | 1 | |a Han, Xiaodong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yan, Chao |e VerfasserIn |4 aut | |
| 700 | 1 | |a Qiu, Yudong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cheng, Hao |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advanced science |d Weinheim : Wiley-VCH, 2014 |g 12(2025), 42 vom: Nov., Artikel-ID e10071, Seite 1-18 |h Online-Ressource |w (DE-627)817357777 |w (DE-600)2808093-2 |w (DE-576)425795926 |x 2198-3844 |7 nnas |a SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer |
| 773 | 1 | 8 | |g volume:12 |g year:2025 |g number:42 |g month:11 |g elocationid:e10071 |g pages:1-18 |g extent:18 |a SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1002/advs.202510071 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202510071 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260113 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1015235425 |a Kong, Bo |m 1015235425:Kong, Bo |d 910000 |d 910200 |d 50000 |e 910000PK1015235425 |e 910200PK1015235425 |e 50000PK1015235425 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 18 | ||
| 999 | |a KXP-PPN1948551527 |e 4845989166 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Zuerst veröffentlicht: 20. August 2025","Gesehen am 13.01.2026"],"physDesc":[{"extent":"18 S.","noteIll":"Illustrationen"}],"name":{"displayForm":["Hexing Hang, Mengyu Yu, Linxi Zhu, Neng Tang, Xiao Fu, Zhenghua Cai, Minghao Yan, Yi Chen, Lei Yang, Jianzhuang Wu, Jiatong Tang, Yu Xie, Qi Li, Xu Fu, Liang Mao, Jun Chen, Fanqing Meng, Bo Kong, Xiaodong Han, Chao Yan, Yudong Qiu, and Hao Cheng"]},"person":[{"given":"Hexing","family":"Hang","role":"aut","display":"Hang, Hexing","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Yu, Mengyu","given":"Mengyu","family":"Yu"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Zhu, Linxi","given":"Linxi","family":"Zhu"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Tang, Neng","given":"Neng","family":"Tang"},{"given":"Xiao","family":"Fu","display":"Fu, Xiao","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Cai, Zhenghua","given":"Zhenghua","family":"Cai"},{"roleDisplay":"VerfasserIn","display":"Yan, Minghao","role":"aut","family":"Yan","given":"Minghao"},{"given":"Yi","family":"Chen","role":"aut","display":"Chen, Yi","roleDisplay":"VerfasserIn"},{"given":"Lei","family":"Yang","role":"aut","display":"Yang, Lei","roleDisplay":"VerfasserIn"},{"display":"Wu, Jianzhuang","role":"aut","roleDisplay":"VerfasserIn","given":"Jianzhuang","family":"Wu"},{"given":"Jiatong","family":"Tang","role":"aut","display":"Tang, Jiatong","roleDisplay":"VerfasserIn"},{"family":"Xie","given":"Yu","display":"Xie, Yu","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Qi","family":"Li","roleDisplay":"VerfasserIn","display":"Li, Qi","role":"aut"},{"family":"Fu","given":"Xu","roleDisplay":"VerfasserIn","display":"Fu, Xu","role":"aut"},{"role":"aut","display":"Mao, Liang","roleDisplay":"VerfasserIn","family":"Mao","given":"Liang"},{"display":"Chen, Jun","role":"aut","roleDisplay":"VerfasserIn","given":"Jun","family":"Chen"},{"family":"Meng","given":"Fanqing","roleDisplay":"VerfasserIn","role":"aut","display":"Meng, Fanqing"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Kong, Bo","family":"Kong","given":"Bo"},{"given":"Xiaodong","family":"Han","display":"Han, Xiaodong","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Yan, Chao","family":"Yan","given":"Chao"},{"display":"Qiu, Yudong","role":"aut","roleDisplay":"VerfasserIn","given":"Yudong","family":"Qiu"},{"role":"aut","display":"Cheng, Hao","roleDisplay":"VerfasserIn","given":"Hao","family":"Cheng"}],"recId":"1948551527","id":{"doi":["10.1002/advs.202510071"],"eki":["1948551527"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"id":{"zdb":["2808093-2"],"issn":["2198-3844"],"eki":["817357777"],"doi":["10.1002/(ISSN)2198-3844"]},"recId":"817357777","physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2014 (Dezember)-"],"note":["Gesehen am 21.10.2022"],"title":[{"title_sort":"Advanced science","title":"Advanced science"}],"origin":[{"publisher":"Wiley-VCH","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Weinheim"}],"disp":"SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancerAdvanced science","part":{"issue":"42","year":"2025","pages":"1-18","extent":"18","volume":"12","text":"12(2025), 42 vom: Nov., Artikel-ID e10071, Seite 1-18"},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"November 13, 2025","dateIssuedKey":"2025"}],"titleAlt":[{"title":"SPone-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer"}],"title":[{"title_sort":"SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer","title":"SP1-mediated glycolytic reprogramming promotes tumorigenesis and progression in pancreatic cancer"}],"language":["eng"]} | ||
| SRT | |a HANGHEXINGSP1MEDIATE1320 | ||